Dublin, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The "Patent Strategies for Generic Medicines and Generic Medicine Companies Training Course (Oct 21, 2025)" has been added to ResearchAndMarkets.com's ...
Enthusiasm for Michael Saylor's Strategy (MSTR) — and some of its numerous imitators — has been fading, with the stocks for some of those companies tumbling over the past month. Over Sunday night, the ...
Donald Trump announced 100% tariffs on imported branded or patented pharmaceutical products from October 1, 2025, unless companies build US manufacturing facilities. This policy primarily impacts ...
In this MW180 episode we look at Audi’s shift in model naming strategy and why it still creates confusion among enthusiasts and customers. The discussion covers what these changes mean for the brand ...
No double-digit favorites have lost yet in the 2025 NFL season, but Week 3 did bring perhaps the biggest upset of the year thus far as the Packers fell to the Browns as 7.5-point favorites. That was ...
Focus on coordinating across silos and adapting to change on the front lines. by Donald Sull, Rebecca Homkes and Charles Sull Since Michael Porter’s seminal work in the 1980s we have had a clear and ...
There's no doubt that Microsoft's multibillion-dollar partnership with OpenAI has been under immense strain and tension, especially with the latter's plan to evolve into a for-profit venture to avoid ...
Many successful companies have made the transition from the Real World (RL) to a three-dimensional realm called Second Life (SL)—a virtual world steeped in commercialism. The rationale behind these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback